Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography–guided Salvage Radiotherapy Following Prostatectomy

For patients who experience recurrence of prostate cancer after surgical removal of their prostate, salvage radiotherapy (sRT) is a further treatment option. We found that a type of scan called PSMA PET (prostate-specific membrane antigen positron emission tomography) to identify recurrence and guide sRT can improve recurrence-free survival because of better targeting of pelvic lymph nodes that may contain cancer cells.

Authors

Institutions

Publication Details

Journal
European Urology Focus
Published
2024-11-27
DOI
https://doi.org/10.1016/j.euf.2024.11.006
Citations
6
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
2.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography–guided Salvage Radiotherapy Following Prostatectomy

Thomas Wiegel, Konstantinos P. Ferentinos, Simon K. B. Spohn, Matthias Gückenberger et al.
6 citations
European Urology Focus
Prostate Cancer Treatment and Research
2.51
article

Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography–guided Salvage Radiotherapy Following Prostatectomy

Thomas Wiegel, Konstantinos P. Ferentinos, Simon K. B. Spohn, Matthias Gückenberger, Claus Belka, Anca-Ligia Grosu, Nina-Sophie Schmidt-Hegemann, Mohamed Shelan, Stefanie Hayoz, Louise Emmett, Stefano Fanti, Stefan A. Koerber, Jan Caspar Peeken, Iosif Strouthos, Stephanie Kroeze, Francesco Ceci, Martin Wolkewitz, Daniel M. Aebersold, Constantinos Zamboglou, Andrea Farolfi, George Hruby, Pirus Ghadjar, Alexis Vrachimis, Paulina Staus
article en
6 citations

Abstract

For patients who experience recurrence of prostate cancer after surgical removal of their prostate, salvage radiotherapy (sRT) is a further treatment option. We found that a type of scan called PSMA PET (prostate-specific membrane antigen positron emission tomography) to identify recurrence and guide sRT can improve recurrence-free survival because of better targeting of pelvic lymph nodes that may contain cancer cells.

European Urology FocusVol. 11(2)
University of Bern (CH), The University of Sydney (AU), Universität Ulm (DE), European University Cyprus (CY), University of Zurich (CH), Royal North Shore Hospital (AU), University Hospital of Bern (CH), LMU Klinikum (DE), University Hospital of Zurich (CH), Azienda USL di Bologna (IT), Swiss Group For Clinical Cancer Research (CH), Kantonsspital Aarau (CH), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE)
Research and Innovation Foundation
Zero hunger
Openalex Percentile: Top 10%
Prostate Cancer Treatment and Research
2.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.